131I SGMIB-ZT-199

N/A

Report date: 2025/10/20 14:27:07

Base Information

Drug Name131I SGMIB-ZT-199

Drug Alias Name131I-SGMIB-ZT-199

ClassificationRadiation-emitting products > Nuclides > Iodine > 131IRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulators

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaClinical

Originator CompaniesHuashan Hospital

China Registration ClassN/A

Develop Information

Active CompaniesHuashan Hospital

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A